Post-doc to develop novel in vivo genome editing approaches for therapy of inherited diseases.
The project founded by the European Union aims to improve in vivo genome editing in liver and retina to obtain persistent hepatic transduction and to counteract autosomal dominant retinitis pigmentosa. We develop AAV-based strategies for genome editing from in vitro to animal models.
We are seeking enthusiastic and outstanding post-doctoral candidates with a strong background in molecular biology, gene therapy and genome editing. The candidates will have the opportunity to develop novel genome editing strategies and test their therapeutic potential in vivo.
- A solution-oriented, organisational and positive mindset is required
- The ability to work in a highly collaborative environment both independently and as part of the team is essential
- Good publication record with evidence of independence
- Previous experience abroad is preferred
- Fluency in written and spoken English
- Experience with molecular biology and cloning is required
- Experience with cell culture, biochemical assays, histology is preferred but not strictly required
For further information visit our website: https://www.tigem.it/research/research-faculty/auricchio
or contact Professor Alberto Auricchio at email@example.com
How to apply
Please send your CV and a motivation letter to: firstname.lastname@example.org